Pfizer Inc. (PFE): Price and Financial Metrics


Pfizer Inc. (PFE): $40.15

-0.53 (-1.30%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PFE POWR Grades


  • Value is the dimension where PFE ranks best; there it ranks ahead of 92.11% of US stocks.
  • The strongest trend for PFE is in Value, which has been heading up over the past 31 weeks.
  • PFE's current lowest rank is in the Momentum metric (where it is better than 11.83% of US stocks).

PFE Stock Summary

  • PFE has a market capitalization of $222,844,192,845 -- more than approximately 99.29% of US stocks.
  • PFE's went public 35.46 years ago, making it older than 92.77% of listed US stocks we're tracking.
  • The volatility of Pfizer Inc's share price is greater than that of only 2.5% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Pfizer Inc are INTC, BHP, CSCO, LLY, and NVS.
  • Visit PFE's SEC page to see the company's official filings. To visit the company's web site, go to www.pfizer.com.

PFE Price Target

For more insight on analysts targets of PFE, see our PFE price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $42.62 Average Broker Recommendation 1.82 (Hold)

PFE Stock Price Chart Interactive Chart >

Price chart for PFE

PFE Price/Volume Stats

Current price $40.15 52-week high $43.08
Prev. close $40.68 52-week low $31.61
Day low $39.95 Volume 21,386,900
Day high $40.67 Avg. volume 30,618,625
50-day MA $38.79 Dividend yield 3.89%
200-day MA $37.16 Market Cap 224.75B

Pfizer Inc. (PFE) Company Bio


Pfizer Inc. is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products. Pfizer was founded under its original name, Charles Pfizer & Company, in 1849 in Brooklyn, New York by Charles Pfizer and Charles Erhart. The company operates research and development facilities in United States and the United Kingdom and employs over 78,000 individuals worldwide. Some of the company’s more recognizable brands include Advil, Celebrex, Chantix, Chapstick, Dimetapp, Lipitor, Robitussin, and Viagra. Albert Bourla serves as Pfizer’s Chairman of the Board and Chief Executive Officer and the company is headquartered in New York, New York.


PFE Latest News Stream


Event/Time News Detail
Loading, please wait...

PFE Latest Social Stream


Loading social stream, please wait...

View Full PFE Social Stream

Latest PFE News From Around the Web

Below are the latest news stories about Pfizer Inc that investors may wish to consider to help them evaluate PFE as an investment opportunity.

Johnson & Johnson Can’t Use 60 Million Covid Doses Because of Possible Contamination, FDA Rules

The government agency based the decision on quality-control problems at the Emergent BioSolutions plant where the vaccine was made.

Yahoo | June 11, 2021

Seattle becomes first major U.S.city with 70% fully vaccinated

Seattle Mayor Jenny Durkan joined Yahoo Finance to break down how her city has been so sucsseful in distrubting vaccines. 

Yahoo | June 11, 2021

COVID SCIENCE-Vaccines effective vs variants despite diminished antibodies; kids may be as contagious as adults

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. The one-dose Johnson & Johnson COVID-19 vaccine and the two-dose vaccine from Pfizer and BioNTech appear to protect against worrisome coronavirus variants despite diminished levels of antibodies that can neutralize the newer versions of the virus, two studies in the journal Nature suggest.

Yahoo | June 11, 2021

Moderna Says No Link Between COVID-19 Jab And Heart Inflammation

Moderna Inc (NASDAQ: MRNA) says there is no “causal association” between its COVID-19 vaccine and cases of myocarditis or pericarditis, based on a review of safety data. The Centers for Disease Control and Prevention (CDC) has identified 216 cases of heart inflammation after the first dose of an mRNA shot and another 573 cases after the second dose, Bloomberg reported. The median age of people with myocarditis or pericarditis following the first dose was 30 and 24 in the second-dose cases. There

Yahoo | June 11, 2021

CDC plans 'emergency meeting' over COVID-19 vaccine side effects

Yahoo Finance's Anjalee Khemlani reports on the CDC's plans for an 'emergency meeting' over COVID-19 vaccine side effects.

Yahoo | June 11, 2021

Read More 'PFE' Stories Here

PFE Price Returns

1-mo 0.32%
3-mo 14.50%
6-mo 5.88%
1-year 30.78%
3-year 31.27%
5-year 46.33%
YTD 11.35%
2020 3.23%
2019 -6.91%
2018 24.82%
2017 15.90%
2016 4.42%

PFE Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full PFE Dividend History

Continue Researching PFE

Want to see what other sources are saying about Pfizer Inc's financials and stock price? Try the links below:

Pfizer Inc (PFE) Stock Price | Nasdaq
Pfizer Inc (PFE) Stock Quote, History and News - Yahoo Finance
Pfizer Inc (PFE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8193 seconds.